Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › PA › Dickson City › NPI 1023199098
Physician

Pediatrics of Nepa, PC

Pediatrics of Nepa, PC was paid $2.61M by Medicaid between Jan 2018 and Dec 2024, across 49 billing codes. Its largest line is 0202U, Oncology (prostate), multianalyte, gene expression profiling — 30% of everything it billed.

33Billing provider infoPEDIATRICS OF NEPA, PC
DICKSON CITY, PA 18519
33aNPI1023199098assigned 10/18/2006
33bProvider typePediatrics Physician
28Total paid$2.61M
24GClaims51,742
24DCodes billed49
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Pediatrics Physician providers in Pennsylvania

Rank by total paid#29 of 1,257
Median peer was paid$45K
This provider vs. median57×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$50K$100K$150K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018628$9K
2019360$15K
20201,833$58K
202112,332$766K
202214,169$839K
202312,585$505K
2024incomplete9,835$415K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
0202U Oncology (prostate), multianalyte, gene expression profiling 30% 3,436 3,392 $792K
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 19% 14,361 13,554 $491K
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 15% 7,695 7,266 $398K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV 8.8% 2,124 1,998 $231K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 8.0% 2,258 2,213 $209K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 7.2% 2,216 2,149 $187K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) 4.5% 1,421 1,409 $117K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 4.2% 1,341 1,307 $108K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 440 436 $16K
96127 <1% 1,648 1,619 $6K
87430 <1% 742 723 $5K
90688 <1% 2,151 2,065 $5K
37 more codes
0002A <1% 104 $4K
90670 <1% 1,254 $4K
90460 Immunization administration through 18 years of age via any route, first or only component <1% 170 $4K
90698 <1% 1,776 $4K
0001A <1% 95 $4K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 292 $3K
90680 <1% 1,181 $3K
0071A <1% 60 $2K
87070 <1% 246 $2K
90744 <1% 816 $2K
90633 <1% 1,020 $2K
90687 <1% 992 $1K
90734 <1% 344 $1K
0072A <1% 30 $1K
90651 <1% 748 $1K
90671 <1% 70 $916.60
90619 <1% 13 $733.31
90715 <1% 344 $386.81
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 12 $286.00
99051 <1% 58 $233.84
90696 <1% 82 $150.00
90707 <1% 185 $140.00
83718 <1% 12 $84.00
82465 <1% 12 $72.00
90716 <1% 172 $50.00
99000 <1% 40 $40.00
92551 <1% 39 $16.00
99173 <1% 88 $12.00
90657 0% 156 $0.00
91307 0% 355 $0.00
94760 0% 70 $0.00
90710 0% 153 $0.00
91300 0% 516 $0.00
90658 0% 307 $0.00
Q2038 Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone) 0% 51 $0.00
91308 0% 12 $0.00
91312 0% 34 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialMARX, JOHN (PARTNER)